TL;DR
This study investigates the effectiveness of radioactive seed 125I implantation under CT-guidance for treating breast cancer bone metastases. The findings suggest this method significantly improves therapeutic outcomes, reduces pain, and lowers tumor markers compared to conventional treatments, making it a promising option for patients.
What Problem Does This Paper Address?
Breast cancer is a growing concern, and bone metastases are a common and debilitating complication, affecting up to 71% of patients. Traditional treatments like surgery, chemotherapy, and radiotherapy, while effective to some extent, often come with significant postoperative complications and adverse reactions such as bone marrow suppression and nausea. These issues can severely impact a patient's quality of life. The paper addresses the need for more effective and less burdensome treatments for breast cancer bone metastases, aiming to improve therapeutic efficacy while minimizing patient suffering.
Methods
The study employed a comparative approach, dividing 90 breast cancer patients with bone metastases into two groups: a control group and an experimental group, each with 45 patients.
- Control Group: Received conventional treatment, primarily strontium chloride (89Sr) injection. This involved specific dosages, slow intravenous administration, and regular blood monitoring to ensure patient safety and adjust treatment as needed.
- Experimental Group: Underwent radioactive seed 125I implantation guided by CT. This involved:
- Pre-treatment physical and laboratory assessments (liver function, blood routine, kidney function).
- Utilizing CT imaging and a Treatment Planning System (TPS) to precisely locate lesions and calculate the optimal number and arrangement of 125I seeds for continuous gamma ray release to inhibit tumor growth.
- Local anesthesia and seed implantation using a specialized needle, with intermittent CT scanning to ensure accurate placement.
- Monitoring of vital signs and prompt management of any complications.
The therapeutic effect was evaluated based on pain intensity (using a Visual Analogue Scale - VAS), tumor marker levels (CEA, CA153, CA125), and an efficacy evaluation divided into four grades, with grades I and II considered effective.
Datasets
The study utilized data from 90 breast cancer patients admitted to the hospital between January 2017 and January 2018. No new datasets were introduced; the data comprises patient clinical information and treatment outcomes.
Key Insights and Ideas
- Targeted, Continuous Treatment: The core innovation lies in using CT-guidance for precise implantation of radioactive seeds. This allows for continuous, uninterrupted delivery of radiation directly to the tumor site, a significant advantage over systemic treatments.
- Minimizing Side Effects: By targeting the metastatic lesions directly, the approach aims to reduce systemic exposure to radiation and chemotherapy, thereby potentially mitigating common side effects like bone marrow suppression and nausea.
- Multifaceted Improvement: The study highlights that the radioactive seed implantation not only combats tumor growth but also demonstrably alleviates pain and reduces key tumor markers, suggesting a comprehensive improvement in patient well-being.
Key Results
- Pain Reduction: The experimental group showed significantly lower pain intensity after treatment compared to the control group (P<0.05).
- Improved Efficacy: The total effective rate in the experimental group was significantly higher (71.11%) than in the control group (42.22%) (P<0.05).
- Reduced Tumor Markers: Levels of CEA, CA153, and CA125 were significantly lower in the experimental group after treatment compared to the control group (P<0.05). For example, CEA levels were (3.67±1.03) ng/mL in the experimental group versus (4.76±1.23) ng/mL in the control group.
Limitations and Future Work
- Sample Size: While 90 patients were included, the authors do not explicitly discuss limitations related to sample size or statistical power for specific subgroup analyses.
- Generalizability: The study was conducted at a single hospital, and the findings might need validation across multiple centers to confirm broader applicability.
- Long-term Outcomes: The paper focuses on immediate post-treatment effects. Long-term survival rates, recurrence rates, and the durability of pain relief are not detailed, representing an area for future investigation.
- Cost-Effectiveness: While the treatment shows promise, a detailed cost-effectiveness analysis compared to conventional methods would be valuable for clinical adoption.
The authors conclude that radioactive seed 125I implantation under CT-guidance is a valuable and effective treatment for breast cancer bone metastases, warranting promotion and wider use. Future research could focus on long-term follow-up studies and comparative analyses with other advanced treatment modalities.
Summary updated